arsenic has been researched along with Multiple Sclerosis, Relapsing-Remitting in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aliomrani, M; Amini, M; Beh-Pajooh, A; Ghahremani, MH; Hasani Nourian, Y; Hosseini, R; Mohammadi, S; Sahraian, MA | 1 |
| Akbari, M; Asadikaram, G; Ebrahimi, G; Juybari, KB; Karimi, A; Mirzamohammadi, S; Momeni Moghaddam, MA; Nematollahi, MH; Torkzadeh-Mahani, M | 1 |
2 other study(ies) available for arsenic and Multiple Sclerosis, Relapsing-Remitting
| Article | Year |
|---|---|
Changes in DNA methylation in APOE and ACKR3 genes in multiple sclerosis patients and the relationship with their heavy metal blood levels.
Topics: Adult; Apolipoproteins E; Arsenic; Cadmium; Case-Control Studies; DNA Methylation; Female; Genes; Humans; Male; Metals, Heavy; Multiple Sclerosis, Relapsing-Remitting; Real-Time Polymerase Chain Reaction; Receptors, CXCR | 2021 |
Evaluation of serum arsenic and its effects on antioxidant alterations in relapsing-remitting multiple sclerosis patients.
Topics: Adult; Arsenic; Case-Control Studies; Female; Humans; Lactic Acid; Male; Malondialdehyde; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Oxidative Stress; Reactive Oxygen Species | 2018 |